Windlas Biotech - Quaterly Results

08 Nov 2022 Evaluate
A fair growth of 15.17% in the revenue at Rs. 1327.30 millions was reported in the September 2022 quarter as compared to Rs. 1152.52 millions during year-ago period.Net Profit recorded in the quarter ended September 2022 rise to 46.64% to Rs. 122.09  millions  compared to R. 83.26 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 186.70 millions from 144.01 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1327.30 1152.52 15.17 2526.66 2262.08 11.70 4659.30 4276.02 8.96
Other Income 26.11 12.19 114.19 54.69 19.08 186.64 67.06 30.94 116.74
PBIDT 186.70 144.01 29.64 353.20 274.75 28.55 596.01 577.86 3.14
Interest 1.15 4.36 -73.62 4.65 9.18 -49.35 14.17 12.90 9.84
PBDT 185.55 139.65 32.87 348.55 265.57 31.25 581.84 241.45 140.98
Depreciation 29.05 30.75 -5.53 56.61 61.00 -7.20 121.47 129.65 -6.31
PBT 156.50 108.90 43.71 291.94 204.57 42.71 460.37 111.80 311.78
TAX 34.41 25.64 34.20 71.85 54.44 31.98 74.76 61.70 21.17
Deferred Tax -2.86 -2.12 34.91 -1.90 -2.19 -13.24 -26.57 13.28 -300.08
PAT 122.09 83.26 46.64 220.09 150.13 46.60 385.61 50.10 669.68
Equity 108.97 108.97 0.00 108.97 108.97 0.00 108.97 64.11 69.97
PBIDTM(%) 14.07 12.50 12.57 13.98 12.15 15.09 12.79 13.51 -5.34

Windlas Biotech Share Price

798.95 -11.00 (-1.36%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×